68 related articles for article (PubMed ID: 27898360)
1. Novel oral administrated paclitaxel micelles with enhanced bioavailability and antitumor efficacy for resistant breast cancer.
Zhang T; Luo J; Fu Y; Li H; Ding R; Gong T; Zhang Z
Colloids Surf B Biointerfaces; 2017 Feb; 150():89-97. PubMed ID: 27898360
[TBL] [Abstract][Full Text] [Related]
2. Improved oral absorption and anti-lung cancer activity of paclitaxel-loaded mixed micelles.
Hou J; Sun E; Zhang ZH; Wang J; Yang L; Cui L; Ke ZC; Tan XB; Jia XB; Lv H
Drug Deliv; 2017 Nov; 24(1):261-269. PubMed ID: 28165804
[TBL] [Abstract][Full Text] [Related]
3. A simple reduction-sensitive micelles co-delivery of paclitaxel and dasatinib to overcome tumor multidrug resistance.
Li J; Xu R; Lu X; He J; Jin S
Int J Nanomedicine; 2017; 12():8043-8056. PubMed ID: 29138561
[TBL] [Abstract][Full Text] [Related]
4. l-Carnitine conjugated chitosan-stearic acid polymeric micelles for improving the oral bioavailability of paclitaxel.
Yang T; Feng J; Zhang Q; Wu W; Mo H; Huang L; Zhang W
Drug Deliv; 2020 Dec; 27(1):575-584. PubMed ID: 32306775
[TBL] [Abstract][Full Text] [Related]
5. Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model.
Parayath NN; Nehoff H; Norton SE; Highton AJ; Taurin S; Kemp RA; Greish K
Int J Nanomedicine; 2016; 11():3979-91. PubMed ID: 27574427
[TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers.
Patra A; Satpathy S; Shenoy AK; Bush JA; Kazi M; Hussain MD
Int J Nanomedicine; 2018; 13():2869-2881. PubMed ID: 29844670
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.
Sheihet L; Garbuzenko OB; Bushman J; Gounder MK; Minko T; Kohn J
Eur J Pharm Sci; 2012 Feb; 45(3):320-9. PubMed ID: 22155544
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Antitumor Effects on Drug-Resistant Breast Cancer of Paclitaxel/Lapatinib Composite Nanocrystals.
Wang J; Lv FM; Wang DL; Du JL; Guo HY; Chen HN; Zhao SJ; Liu ZP; Liu Y
Molecules; 2020 Jan; 25(3):. PubMed ID: 32019194
[TBL] [Abstract][Full Text] [Related]
9. Naturally sourced amphiphilic peptides as paclitaxel vehicles for breast cancer treatment.
Chen R; Liu E; Fang Y; Gao N; Zhang M; Zhang X; Chen W; Liang C; Zhang Y; Huang Y
Biomater Adv; 2024 May; 159():213824. PubMed ID: 38490019
[TBL] [Abstract][Full Text] [Related]
10. Combating multidrug resistance of breast cancer with ginsenoside Rh2-irrigated nano-in-thermogel.
Long J; Hu W; Ren T; Wang X; Lu C; Pan X; Wu C; Peng T
Int J Pharm; 2024 Jan; 650():123718. PubMed ID: 38104849
[TBL] [Abstract][Full Text] [Related]
11. Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation.
He Z; Schulz A; Wan X; Seitz J; Bludau H; Alakhova DY; Darr DB; Perou CM; Jordan R; Ojima I; Kabanov AV; Luxenhofer R
J Control Release; 2015 Jun; 208():67-75. PubMed ID: 25725361
[TBL] [Abstract][Full Text] [Related]
12. Multi-functional Chitosan Polymeric Micelles for improving the oral bioavailability of Paclitaxel based on synergistic effect.
Zhang W; Zhang Q; Yang Y; Chen Y; Wei J; Lu F; Li D
Drug Deliv Transl Res; 2024 Apr; ():. PubMed ID: 38643258
[TBL] [Abstract][Full Text] [Related]
13. Mechanochemical preparation of chrysomycin A self-micelle solid dispersion with improved solubility and enhanced oral bioavailability.
Xu Z; Zheng S; Gao X; Hong Y; Cai Y; Zhang Q; Xiang J; Xie D; Song F; Zhang H; Wang H; Sun X
J Nanobiotechnology; 2021 May; 19(1):164. PubMed ID: 34059070
[TBL] [Abstract][Full Text] [Related]
14. Effective therapy of advanced breast cancer through synergistic anticancer by paclitaxel and P-glycoprotein inhibitor.
Zhu S; Sun C; Cai Z; Li Y; Liu W; Luan Y; Wang C
Mater Today Bio; 2024 Jun; 26():101029. PubMed ID: 38545262
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers.
Yu J; Hu F; Zhu Q; Li X; Ren H; Fan S; Qian B; Zhai B; Yang D
Nanoscale Res Lett; 2020 Mar; 15(1):59. PubMed ID: 32166458
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein.
Xu W; Xiao Y; Zheng L; Xu M; Jiang X; Wang L
Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140044
[TBL] [Abstract][Full Text] [Related]
17. Optimizing Paclitaxel Oral Absorption and Bioavailability: TPGS Co-Coating via Supercritical Anti-Solvent Fluidized Bed Technology.
Zhong Z; Lan Y; Chen J; Ping L; Li X; Wang Q; Zhuang X; Qiu Z; Yuan T; Guo Q; Xi L; Li Q; Luo D
Pharmaceuticals (Basel); 2024 Mar; 17(4):. PubMed ID: 38675374
[TBL] [Abstract][Full Text] [Related]
18. Wheat germ agglutinin modified mixed micelles overcome the dual barrier of mucus/enterocytes for effective oral absorption of shikonin and gefitinib.
Hou X; Ai X; Liu Z; Yang J; Wu Y; Zhang D; Feng N
Drug Deliv Transl Res; 2024 Apr; ():. PubMed ID: 38656402
[TBL] [Abstract][Full Text] [Related]
19. Nanosuspension delivery of paclitaxel to xenograft mice can alter drug disposition and anti-tumor activity.
Chiang PC; Gould S; Nannini M; Qin A; Deng Y; Arrazate A; Kam KR; Ran Y; Wong H
Nanoscale Res Lett; 2014 Apr; 9(1):156. PubMed ID: 24685243
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel/oxaliplatin/fluorouracil (TOF) regimen versus S-1/oxaliplatin (SOX) regimen for metastatic gastric cancer patients.
Dai X; Zhang X; Wang C; Jiang J; Wu C
Oncotarget; 2017 May; 8(18):30495-30501. PubMed ID: 27911869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
